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Despite wide-spread use of disposable bioreactors, there is a lack of well-established scale-down model for 
larger scale SUBs. Here we report a case of NS0 cell culture process transfer from 2000L stainless steel 
bioreactor (SST) to 2000L disposable bioreactor (SUB).  Initial attempts in trying to grow the NS0 cells in 
the small scale 2D bags yielded non-satisfactory results, as growth was impacted by bag material type as 
well as by suppliers of the same bag material type. However, 3D bags of 50L and above proved to be 
supportive of the NS0 cell line growth.  
 
Even for cell lines that do not have growth issues in SUBs, surprising product quality difference between 
SUBs and traditional bench top glass bioreactors are still being observed, thus making the bench top glass 
bioreactors non-ideal as scale down models.  We report two cases where glycan profiles of the expressed 
antibody products show such dramatic differences.  In one case, extensive testing of glass bioreactors from 
various suppliers led to a particular type being able to mimic the glycan profiles from the SUB, whereas in 
the other case, alternative scale down model had to be identified and the process had to be modified to 
maintain the glycan profiles when scaling up to the 200L SUB. 
 
